Global Osteoporosis Market, Patients, Companies & Forecast

Renub Research has announced the addition of the "Global Osteoporosis Market, Patients, Companies & Forecast" report to its offering
By: www.renub.com
 
NOIDA, India - Oct. 30, 2015 - PRLog -- Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.

This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:

1)    Osteoporosis Patients & Forecast

2)    Hip fracture Patients & Forecast

3)    Osteoporosis Market & Forecast

4)    Country Wise Osteoporosis level of Awareness, Guidelines & Policy

5)    Country Wise Reimbursement of Medication

6)    Company Wise Osteoporosis Drugs Sales & Forecast

All the 10 Countries studied in the report are as follows

1)     India

2)     China

3)     Japan

4)     Korea

5)     Brazil

6)     Russia

7)     United Kingdom

8)     France

9)     Germany

10)     United States

Worldwide Osteoporosis – Company Wise Drugs Sales Analysis (2010 – 2019)

1)    Merck

2)    Sanofi

3)    Novartis

4)    Eli Lilly

5)    Amgen

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Click here to view the report details:http://www.renub.com/global-osteoporosis-market-patients-...

For more information visit: http://www.renub.com/

Contact Us

Rajat Gupta

Sr. Manager

Sales & Marketing Div

Renub Research

Email: rajat.gupta@renub.com

Phone:  Phone:  +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)

Web: http://www.renub.com
End
Source:www.renub.com
Email:***@renub.com
Posted By:***@renub.com Email Verified
Tags:Osteoporosis,Osteoporosis
Industry:Business
Location:Noida - Uttar Pradesh - India
Subject:Companies
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Renub Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share